ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00055367
Recruitment Status : Completed
First Posted : February 28, 2003
Last Update Posted : June 16, 2016
Sponsor:
Collaborator:
Elan Pharmaceuticals
Information provided by (Responsible Party):
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2004
  Actual Study Completion Date : May 2004